NASDAQ

Gilead Sciences, Inc. (GILD)

♥ 606 Thanks from members

Live price chart, market sentiment, and community perspectives for Gilead Sciences, Inc. (NASDAQ: GILD).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Michael L. RiordanLeadership: Daniel O'Day (Chairman and CEO)Leadership: Andrew Dickinson (CFO)Holder: Vanguard Group, Inc.Holder: BlackRock, Inc.Holder: Capital Research Global InvestorsBiktarvyVeklury (Remdesivir)YescartaTrodelvy#GILD#Gilead Sciences#Biotech Giant#Nasdaq GILD#Antiviral Drugs